Document is current
Any future updates will be listed below
-
Authors
Cebi, Idil
Graf, Lisa Helene
Schütt, Marion
Hormozi, Mohammad
Klocke, Philipp
Löffler, Moritz
Schneider, Marlieke
Warnecke, Tobias
Gharabaghi, Alireza
Weiss, Daniel https://orcid.org/0000-0003-0447-7132
-
Funding
Funding for this research was provided by:
Michael J. Fox Foundation for Parkinson's Research (Michael J. Fox Foundation for Parkinson's Research)
- License Information
-
More Information
Article History
Received: 15 February 2024
Accepted: 22 October 2024
First Online: 9 November 2024
Declarations
:
: The trial was approved by the local Ethics committee of Tübingen University. All patients provided written informed consent. We confirm that we have read the Journal’s position on issues involved in ethical publication and affirm that this work is consistent with those guidelines.
: Idil Cebi, Lisa Helene Graf, Marion Schütt, Moritz Loeffler, Mohammad Hormozi, Marlieke Schneider, Tobias Warnecke, Alireza Gharabaghi and Daniel Weiss declare that there are no conflicts of interest relevant to this work.
: 1) Research project: (A) Conception, (B) Organization, (C) Execution;2) Statistical Analysis: (A) Design, (B) Execution, (C) Review and Critique;3) Manuscript: (A) Writing of the first draft, (B) Review and Critique.
: Idil Cebi, Lisa Helene Graf, Marion Schütt, Moritz Loeffler, Mohammad Hormozi. Marlieke Schneider, Tobias Warnecke and Alireza Gharabaghi declare that there are no additional disclosures to report. Daniel Weiss received travel grants, consulting fees, speaker’s honoraria, and research support from Abbvie, Abbott, Bial, Boston Scientific, Medtronic, Stadapharm.
